Jon Patton | Director, IR and Communication |
Matt Coffey | President and CEO |
Tom Heineman | Global Head, Clinical Development and Operations |
Andrew de Guttadauro | Global Head, Business Development |
Kirk Look | CFO |
John Newman | Canaccord |
Patrick Trucchio | H.C. Wainwright |
Good morning. And welcome to Oncolytics Biotech’s Second Quarter 2021 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the Company’s request.